Sun Valley Arthritis Ltd, Glendale Report issue

Academic/Hospital

Organization Overview

First Clinical Trial
2006
NCT00928837
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2006

Timeline

NOW
  • Now

Alternative names

Sun Valley Arthritis Ltd, 6525 W. Sack Drive Suite 108 Glendale AZ 85308 Phone 623-825-5591 Fax 623 | Sun Valley Arthritis Ltd. 6525 W. Sack Drive Suite 108 Glendale AZ 85308 Phone 623-825-5591 Fax 623-362-9264

Active Ingredients

Drugs in Other Trials (3)

epicatechin (2 trials)

naproxen (naprosyn) (2 trials)

tj-14 (2 trials)

Indications

Overview

  • Highest Phase: Phase 0
  • # of Trials: 2
  • # of Trial APIs: 3